Latest disclosed round
Series B
- Date
- 2023-01-01
- Amount
- GBP 39.5m
- Sector
- Biotech & techbio
- Companies House
- 10989365
Series B
Grey Wolf Therapeutics
Immuno-oncology
CandidateSeries BOxford
Evidence status
Review retained
- Identity
- Candidate
- Match
- High candidate
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
2 linked investors
Funding record
1 disclosed round
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2023-01-01 | Series B | £39.5M | not specified in source, British Patient Capital (per BPC 2023 direct-investment list) |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.